HEADER CHAPERONE/CHAPERONE INHIBITOR 16-JUN-16 5GGZ TITLE CRYSTAL STRUCTURE OF NOVEL INHIBITOR BOUND WITH HSP90 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: B, A, D, C; COMPND 4 FRAGMENT: UNP RESIDUES 16-225; COMPND 5 SYNONYM: HSP90; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 ROSSETA(DE3) PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS HSP90, CHAPERONE-CHAPERONE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.T.CHEN,J.LI,Y.C.XU REVDAT 2 20-MAR-24 5GGZ 1 REMARK REVDAT 1 08-MAR-17 5GGZ 0 JRNL AUTH F.JIANG,H.J.WANG,Y.H.JIN,Q.ZHANG,Z.H.WANG,J.M.JIA,F.LIU, JRNL AUTH 2 L.WANG,Q.C.BAO,D.D.LI,Q.D.YOU,X.L.XU JRNL TITL NOVEL TETRAHYDROPYRIDO[4,3-D]PYRIMIDINES AS POTENT JRNL TITL 2 INHIBITORS OF CHAPERONE HEAT SHOCK PROTEIN 90 JRNL REF J. MED. CHEM. V. 59 10498 2016 JRNL REFN ISSN 1520-4804 JRNL PMID 27933959 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00912 REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 3 NUMBER OF REFLECTIONS : 68699 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.9268 - 4.8527 0.85 4635 138 0.1734 0.2141 REMARK 3 2 4.8527 - 3.8531 0.87 4652 131 0.1585 0.2199 REMARK 3 3 3.8531 - 3.3664 0.88 4733 142 0.1913 0.2557 REMARK 3 4 3.3664 - 3.0588 0.90 4767 141 0.2124 0.2566 REMARK 3 5 3.0588 - 2.8396 0.91 4818 148 0.2221 0.2741 REMARK 3 6 2.8396 - 2.6722 0.91 4817 147 0.2256 0.2411 REMARK 3 7 2.6722 - 2.5384 0.92 4901 147 0.2240 0.2791 REMARK 3 8 2.5384 - 2.4280 0.92 4860 147 0.2295 0.3473 REMARK 3 9 2.4280 - 2.3345 0.92 4895 150 0.2281 0.2813 REMARK 3 10 2.3345 - 2.2540 0.93 4866 137 0.2384 0.3029 REMARK 3 11 2.2540 - 2.1835 0.93 4952 149 0.2530 0.3667 REMARK 3 12 2.1835 - 2.1211 0.93 4951 145 0.2596 0.3417 REMARK 3 13 2.1211 - 2.0653 0.93 4905 148 0.2694 0.2819 REMARK 3 14 2.0653 - 2.0149 0.75 3957 120 0.2662 0.3348 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6809 REMARK 3 ANGLE : 1.077 9187 REMARK 3 CHIRALITY : 0.045 1041 REMARK 3 PLANARITY : 0.004 1161 REMARK 3 DIHEDRAL : 16.633 2525 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5GGZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1300000735. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68734 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.13300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.52300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, 0.2 M MGCL2, 26% PEG 4000, REMARK 280 PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.29050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 225 REMARK 465 LYS A 225 REMARK 465 LYS C 225 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 211 OE1 GLN C 133 2.14 REMARK 500 O HOH B 416 O HOH B 503 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR B 38 108.13 -162.69 REMARK 500 ASN B 105 -58.68 -135.17 REMARK 500 ALA B 124 29.19 -76.31 REMARK 500 ALA B 166 -145.32 60.93 REMARK 500 SER B 211 44.46 -140.45 REMARK 500 ALA A 166 -142.30 63.05 REMARK 500 TYR D 38 113.16 -162.68 REMARK 500 ALA D 166 -147.31 63.59 REMARK 500 TYR C 38 107.40 -161.46 REMARK 500 THR C 94 42.57 -108.79 REMARK 500 ASN C 105 -59.69 -141.83 REMARK 500 ALA C 166 -148.43 63.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6TN B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6TN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6TN D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6TN C 301 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS BELIEVE THAT THE SEQUENCE IS CORRECT AND THERE ARE THE REMARK 999 TRUE IDENTITIES OF THESE RESIDUES. DBREF 5GGZ B 16 225 UNP P07900 HS90A_HUMAN 16 225 DBREF 5GGZ A 16 225 UNP P07900 HS90A_HUMAN 16 225 DBREF 5GGZ D 16 225 UNP P07900 HS90A_HUMAN 16 225 DBREF 5GGZ C 16 225 UNP P07900 HS90A_HUMAN 16 225 SEQADV 5GGZ VAL B 126 UNP P07900 ALA 126 SEE SEQUENCE DETAILS SEQADV 5GGZ LYS B 225 UNP P07900 GLU 225 SEE SEQUENCE DETAILS SEQADV 5GGZ VAL A 126 UNP P07900 ALA 126 SEE SEQUENCE DETAILS SEQADV 5GGZ LYS A 225 UNP P07900 GLU 225 SEE SEQUENCE DETAILS SEQADV 5GGZ VAL D 126 UNP P07900 ALA 126 SEE SEQUENCE DETAILS SEQADV 5GGZ LYS D 225 UNP P07900 GLU 225 SEE SEQUENCE DETAILS SEQADV 5GGZ VAL C 126 UNP P07900 ALA 126 SEE SEQUENCE DETAILS SEQADV 5GGZ LYS C 225 UNP P07900 GLU 225 SEE SEQUENCE DETAILS SEQRES 1 B 210 GLU VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN SEQRES 2 B 210 LEU MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS SEQRES 3 B 210 GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP SEQRES 4 B 210 ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SEQRES 5 B 210 SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU SEQRES 6 B 210 ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP SEQRES 7 B 210 THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN SEQRES 8 B 210 LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET SEQRES 9 B 210 GLU ALA LEU GLN ALA GLY VAL ASP ILE SER MET ILE GLY SEQRES 10 B 210 GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA SEQRES 11 B 210 GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU SEQRES 12 B 210 GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR SEQRES 13 B 210 VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR SEQRES 14 B 210 LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR SEQRES 15 B 210 LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SEQRES 16 B 210 SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU SEQRES 17 B 210 LYS LYS SEQRES 1 A 210 GLU VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN SEQRES 2 A 210 LEU MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS SEQRES 3 A 210 GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP SEQRES 4 A 210 ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SEQRES 5 A 210 SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU SEQRES 6 A 210 ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP SEQRES 7 A 210 THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN SEQRES 8 A 210 LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET SEQRES 9 A 210 GLU ALA LEU GLN ALA GLY VAL ASP ILE SER MET ILE GLY SEQRES 10 A 210 GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA SEQRES 11 A 210 GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU SEQRES 12 A 210 GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR SEQRES 13 A 210 VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR SEQRES 14 A 210 LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR SEQRES 15 A 210 LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SEQRES 16 A 210 SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU SEQRES 17 A 210 LYS LYS SEQRES 1 D 210 GLU VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN SEQRES 2 D 210 LEU MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS SEQRES 3 D 210 GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP SEQRES 4 D 210 ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SEQRES 5 D 210 SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU SEQRES 6 D 210 ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP SEQRES 7 D 210 THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN SEQRES 8 D 210 LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET SEQRES 9 D 210 GLU ALA LEU GLN ALA GLY VAL ASP ILE SER MET ILE GLY SEQRES 10 D 210 GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA SEQRES 11 D 210 GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU SEQRES 12 D 210 GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR SEQRES 13 D 210 VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR SEQRES 14 D 210 LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR SEQRES 15 D 210 LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SEQRES 16 D 210 SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU SEQRES 17 D 210 LYS LYS SEQRES 1 C 210 GLU VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN SEQRES 2 C 210 LEU MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS SEQRES 3 C 210 GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP SEQRES 4 C 210 ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SEQRES 5 C 210 SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU SEQRES 6 C 210 ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP SEQRES 7 C 210 THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN SEQRES 8 C 210 LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET SEQRES 9 C 210 GLU ALA LEU GLN ALA GLY VAL ASP ILE SER MET ILE GLY SEQRES 10 C 210 GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA SEQRES 11 C 210 GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU SEQRES 12 C 210 GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR SEQRES 13 C 210 VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR SEQRES 14 C 210 LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR SEQRES 15 C 210 LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SEQRES 16 C 210 SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU SEQRES 17 C 210 LYS LYS HET 6TN B 301 26 HET 6TN A 301 26 HET 6TN D 301 26 HET 6TN C 301 26 HETNAM 6TN [2,4-BIS(OXIDANYL)-5-PROPAN-2-YL-PHENYL]-(2-ETHOXY-7,8- HETNAM 2 6TN DIHYDRO-5~{H}-PYRIDO[4,3-D]PYRIMIDIN-6-YL)METHANONE FORMUL 5 6TN 4(C19 H23 N3 O4) FORMUL 9 HOH *409(H2 O) HELIX 1 AA1 GLN B 23 THR B 36 1 14 HELIX 2 AA2 GLU B 42 ASP B 66 1 25 HELIX 3 AA3 PRO B 67 ASP B 71 5 5 HELIX 4 AA4 THR B 99 ASN B 105 1 7 HELIX 5 AA5 ASN B 105 ALA B 111 1 7 HELIX 6 AA6 ALA B 111 ALA B 124 1 14 HELIX 7 AA7 ASP B 127 GLY B 135 5 9 HELIX 8 AA8 VAL B 136 LEU B 143 5 8 HELIX 9 AA9 GLN B 194 LEU B 198 5 5 HELIX 10 AB1 GLU B 199 SER B 211 1 13 HELIX 11 AB2 GLN A 23 THR A 36 1 14 HELIX 12 AB3 GLU A 42 ASP A 66 1 25 HELIX 13 AB4 PRO A 67 GLY A 73 5 7 HELIX 14 AB5 THR A 99 LEU A 107 1 9 HELIX 15 AB6 LYS A 112 ALA A 124 1 13 HELIX 16 AB7 ASP A 127 GLY A 135 5 9 HELIX 17 AB8 VAL A 136 LEU A 143 5 8 HELIX 18 AB9 GLU A 192 LEU A 198 5 7 HELIX 19 AC1 GLU A 199 LYS A 209 1 11 HELIX 20 AC2 GLN D 23 THR D 36 1 14 HELIX 21 AC3 GLU D 42 ASP D 66 1 25 HELIX 22 AC4 PRO D 67 GLY D 73 5 7 HELIX 23 AC5 THR D 99 LEU D 107 1 9 HELIX 24 AC6 LYS D 112 ALA D 124 1 13 HELIX 25 AC7 ASP D 127 GLY D 135 5 9 HELIX 26 AC8 VAL D 136 LEU D 143 5 8 HELIX 27 AC9 GLU D 192 LEU D 198 5 7 HELIX 28 AD1 GLU D 199 LYS D 209 1 11 HELIX 29 AD2 GLN C 23 THR C 36 1 14 HELIX 30 AD3 GLU C 42 ASP C 66 1 25 HELIX 31 AD4 PRO C 67 ASP C 71 5 5 HELIX 32 AD5 THR C 99 ASN C 105 1 7 HELIX 33 AD6 ASN C 105 ALA C 124 1 20 HELIX 34 AD7 ASP C 127 GLY C 135 5 9 HELIX 35 AD8 VAL C 136 LEU C 143 5 8 HELIX 36 AD9 GLU C 192 LEU C 198 5 7 HELIX 37 AE1 GLU C 199 SER C 211 1 13 SHEET 1 AA1 8 GLU B 18 ALA B 21 0 SHEET 2 AA1 8 SER B 169 THR B 174 -1 O PHE B 170 N PHE B 20 SHEET 3 AA1 8 TYR B 160 SER B 164 -1 N ALA B 161 O ARG B 173 SHEET 4 AA1 8 ALA B 145 LYS B 153 -1 N VAL B 150 O TRP B 162 SHEET 5 AA1 8 GLY B 183 LEU B 190 -1 O ILE B 187 N THR B 149 SHEET 6 AA1 8 THR B 88 ASP B 93 -1 N ILE B 91 O VAL B 186 SHEET 7 AA1 8 ILE B 78 ASN B 83 -1 N ASN B 83 O THR B 88 SHEET 8 AA1 8 ILE B 218 LEU B 220 1 O THR B 219 N LEU B 80 SHEET 1 AA2 8 GLU A 18 ALA A 21 0 SHEET 2 AA2 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 AA2 8 TYR A 160 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 AA2 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 AA2 8 GLY A 183 LEU A 190 -1 O LYS A 185 N ILE A 151 SHEET 6 AA2 8 THR A 88 ASP A 93 -1 N LEU A 89 O LEU A 188 SHEET 7 AA2 8 ILE A 78 ASN A 83 -1 N ILE A 81 O THR A 90 SHEET 8 AA2 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SHEET 1 AA3 8 GLU D 18 ALA D 21 0 SHEET 2 AA3 8 SER D 169 THR D 174 -1 O PHE D 170 N PHE D 20 SHEET 3 AA3 8 TYR D 160 SER D 164 -1 N ALA D 161 O ARG D 173 SHEET 4 AA3 8 ALA D 145 LYS D 153 -1 N VAL D 150 O TRP D 162 SHEET 5 AA3 8 GLY D 183 LEU D 190 -1 O LYS D 185 N ILE D 151 SHEET 6 AA3 8 THR D 88 ASP D 93 -1 N ILE D 91 O VAL D 186 SHEET 7 AA3 8 ILE D 78 ASN D 83 -1 N ILE D 81 O THR D 90 SHEET 8 AA3 8 ILE D 218 LEU D 220 1 O THR D 219 N ILE D 78 SHEET 1 AA4 8 GLU C 18 ALA C 21 0 SHEET 2 AA4 8 SER C 169 THR C 174 -1 O PHE C 170 N PHE C 20 SHEET 3 AA4 8 TYR C 160 SER C 164 -1 N ALA C 161 O ARG C 173 SHEET 4 AA4 8 ALA C 145 LYS C 153 -1 N VAL C 150 O TRP C 162 SHEET 5 AA4 8 GLY C 183 LEU C 190 -1 O ILE C 187 N THR C 149 SHEET 6 AA4 8 THR C 88 ASP C 93 -1 N ILE C 91 O VAL C 186 SHEET 7 AA4 8 ILE C 78 ASN C 83 -1 N ASN C 83 O THR C 88 SHEET 8 AA4 8 ILE C 218 LEU C 220 1 O THR C 219 N ILE C 78 SITE 1 AC1 15 ASN B 51 ALA B 55 LYS B 58 ASP B 93 SITE 2 AC1 15 ILE B 96 GLY B 97 MET B 98 LEU B 107 SITE 3 AC1 15 PHE B 138 THR B 184 VAL B 186 HOH B 405 SITE 4 AC1 15 HOH B 444 HOH B 457 TYR D 61 SITE 1 AC2 11 ASN A 51 ALA A 55 ASP A 93 ILE A 96 SITE 2 AC2 11 GLY A 97 PHE A 138 THR A 184 VAL A 186 SITE 3 AC2 11 HOH A 409 HOH A 438 TYR C 61 SITE 1 AC3 11 TYR B 61 ASN D 51 ALA D 55 ASP D 93 SITE 2 AC3 11 ILE D 96 GLY D 97 PHE D 138 THR D 184 SITE 3 AC3 11 VAL D 186 HOH D 421 HOH D 452 SITE 1 AC4 14 TYR A 61 ASN C 51 ALA C 55 LYS C 58 SITE 2 AC4 14 ASP C 93 ILE C 96 GLY C 97 MET C 98 SITE 3 AC4 14 LEU C 107 PHE C 138 THR C 184 VAL C 186 SITE 4 AC4 14 HOH C 414 HOH C 437 CRYST1 66.841 88.581 99.382 90.00 90.08 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014961 0.000000 0.000022 0.00000 SCALE2 0.000000 0.011289 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010062 0.00000